Loading...

MGX METAGENOMI THERAPEUTICS INC Earnings Reports 8-K Filing

MTGN

MGX

METAGENOMI THERAPEUTICS INC

(MGX)

2025 8-K

Financial Results Update

Name Change Announcement

Financial Update

License Agreement Signed

Product Expansion

Financial Statements

Financial Results

Board Appointment

Data Presentation

Financial Results

Gene Therapy Update

External Links:

On November 11, 2025, Metagenomi, Inc. reported its financial results for Q3 2025, providing positive data for its MGX-001 program related to hemophilia A. This filing indicates a significant development for the company.

AI Assistant

METAGENOMI THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.